Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07128316) titled 'LASIK Using Contoura With Phorcides vs. iDesign' on Aug. 12.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Outcomes Assessor).
Primary Sponsor: 59th Medical Wing
Condition:
Myopia
Astigmatism
Intervention:
Device: Contoura Topolyzer with Phorcides
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: September 11, 2023
Target Sample Size: 63
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07128316
Published by HT Dig...